Free Trial

Lemonade (LMND) Set to Release Earnings on Thursday

Lemonade logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Lemonade is expected to report Q3 2026 results before the market opens on November 5. Analysts forecast a loss of $0.5805 per share and revenue of $322.74 million; the earnings call is scheduled for 8:00 a.m. ET.
  • In its latest quarter, Lemonade reported a $0.56 per-share loss in line with estimates and revenue of $294.4 million, up 79.4% year over year and above consensus.
  • LMND shares opened at $45.27, near their 52-week low of $42.70, while analysts maintain a consensus “Hold” rating with a $63.50 target price.
  • MarketBeat previews the top five stocks to own by November 1st.

Lemonade (NYSE:LMND - Get Free Report) is projected to release its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Lemonade to announce earnings of ($0.5805) per share and revenue of $322.74 million for the quarter. Individuals can find conference call details on the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Lemonade (NYSE:LMND - Get Free Report) last announced its quarterly earnings results on Tuesday, July 28th. The company reported ($0.56) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.56). Lemonade had a negative return on equity of 26.78% and a negative net margin of 14.19%. The company had revenue of $294.40 million during the quarter, compared to the consensus estimate of $291.01 million. During the same period in the previous year, the business earned ($0.60) EPS. Lemonade's revenue for the quarter was up 79.4% on a year-over-year basis. On average, analysts expect Lemonade to post ($1.83) EPS for the current fiscal year and ($1.10) EPS for the next fiscal year.

Lemonade Stock Performance

Shares of NYSE LMND opened at $45.27 on Thursday. Lemonade has a fifty-two week low of $42.70 and a fifty-two week high of $99.90. The firm has a market capitalization of $3.50 billion, a PE ratio of -24.74 and a beta of 1.87. The stock's 50-day simple moving average is $48.11 and its 200-day simple moving average is $59.03.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on LMND. Piper Sandler lowered their price target on Lemonade from $75.00 to $51.00 and set a "neutral" rating for the company in a report on Thursday, July 30th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Lemonade in a research note on Thursday, October 15th. Wall Street Zen raised shares of Lemonade from a "sell" rating to a "hold" rating in a report on Saturday, September 19th. Keefe, Bruyette & Woods raised shares of Lemonade from an "underperform" rating to a "market perform" rating and set a $48.00 price objective on the stock in a report on Thursday, July 30th. Finally, Morgan Stanley reduced their price objective on shares of Lemonade from $56.00 to $48.00 and set an "equal weight" rating for the company in a research report on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $63.50.

View Our Latest Report on Lemonade

Insider Buying and Selling

In other news, insider Maya Prosor sold 1,040 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $54.63, for a total value of $56,815.20. Following the completion of the sale, the insider directly owned 186,533 shares of the company's stock, valued at approximately $10,190,297.79. This represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider John Peters sold 2,249 shares of the stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $54.45, for a total value of $122,458.05. Following the completion of the sale, the insider directly owned 73,834 shares of the company's stock, valued at $4,020,261.30. The trade was a 2.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 15,148 shares of company stock valued at $804,250. 12.20% of the stock is owned by company insiders.

Lemonade Company Profile

(Get Free Report)

Lemonade, Inc is a technology-driven insurance company that offers insurance products through digital platforms, including its mobile application and website. The company uses artificial intelligence, automation and data analytics to support policy purchasing, customer service and claims processing.

Lemonade's product offerings include renters, homeowners, car, pet and term life insurance. Coverage and product availability vary by jurisdiction, and some policies are provided through regulated insurance subsidiaries or underwritten in partnership with other insurers.

Founded in 2015 by Daniel Schreiber and Shai Wininger, Lemonade serves customers in the United States and selected European markets, including Germany, the Netherlands, France and the United Kingdom.

Read More

Earnings History for Lemonade (NYSE:LMND)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lemonade Right Now?

Before you consider Lemonade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.

While Lemonade currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines